PMC10292992_01
PMC10292992_02
The clinical course of the present case. BT: body temperature, Neutro: neutrophil count, CRP: C-reactive protein, CBDCA: carboplatin, VP16: etoposide, mPSL: methylprednisolone, AraC: cytarabine
1349-7235-62-1647-g001.jpg
PMC10292992_02_1349-7235-62-1647-g001.jpg
g001
During the second week of the fourth cycle, her neutrophil count was on decline at 3,100 /muL on day 9 (shown in Fig. 1).
Contrast-enhanced computed tomography (CECT) images. CECT performed on day 22 of the fourth R-modified ESHAP session (a) shows thoracoabdominal aortic wall thickening and surrounding fat infiltration (enlarged image, b). CECT on day 22 of the third cycle showed normal findings (c, enlarged image, d).
1349-7235-62-1647-g002.jpg
PMC10292992_02_1349-7235-62-1647-g002.jpg
g002
CECT on day 22 in search for inflammation/infection sites or recurrent DVT. CECT revealed thoracoabdominal aortic wall thickening and surrounding fat infiltration, findings that had not been seen on CT before the fourth cycle of chemotherapy (day 22 of the third cycle) and not related to the site of endovascular abdominal aortic repair (shown in Fig. 2).